TIG provides immediate but temporary protection against the toxin, whereas the tetanus vaccine stimulates the body to produce its own long-lasting antibodies. In cases of potential exposure, TIG is often administered alongside the tetanus vaccine to ensure both immediate passive protection and long-term active immunity. This combination is particularly important in individuals with uncertain or incomplete vaccination histories.
